Vaxcyte, Inc. — Director's Dealing 2024

Dec 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-12-16

Reporting Person: Cowan Elvia (SVP, FINANCE)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-16	Common Stock	M	7716	$25.92	Acquired	19294	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-16	Stock Option (right to buy)	$25.92	M	7716	Disposed	2032-08-08	Common Stock (7716)	Direct

Footnotes

F1: 1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.